
Nucleotides and nucleosides within the airway surface liquid regulate mucociliary clearance (MCC) activities, the primary innate defense mechanism that removes foreign particles and pathogens from airway surfaces. Nucleotide and nucleoside actions in the airways are mediated mainly by two purinergic receptor subtypes, the Gq-coupled ATP/UTP-sensing P2Y2 receptor and the Gs-coupled A2b adenosine receptor. Activation of the A2b receptor results in cyclic AMP-dependent activation of the cystic fibrosis transmebrane regulator (CFTR) Cl- channel and stimulation of ciliary beat frequency. Agonist occupation of the P2Y2 receptor promotes inhibition of Na+ absorption as well as CFTR-dependent and CFTR-independent Cl-secretion, ciliary beating, and mucin secretion.
Adenosine, Nucleotides, Sodium, Receptors, Purinergic, Receptors, Purinergic P1, Nucleosides, Respiratory Mucosa, Adenosine Triphosphate, Chloride Channels, Mucociliary Clearance, Purinergic Agonists, Purinergic P1 Receptor Agonists, Humans
Adenosine, Nucleotides, Sodium, Receptors, Purinergic, Receptors, Purinergic P1, Nucleosides, Respiratory Mucosa, Adenosine Triphosphate, Chloride Channels, Mucociliary Clearance, Purinergic Agonists, Purinergic P1 Receptor Agonists, Humans
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 123 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
